Alpha Tau Medical (Alpha Tau Medical) Debt-to-Equity : 0.16 (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Alpha Tau Medical Debt-to-Equity?

Alpha Tau Medical's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $1.06 Mil. Alpha Tau Medical's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $12.21 Mil. Alpha Tau Medical's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $84.48 Mil. Alpha Tau Medical's debt to equity for the quarter that ended in Dec. 2023 was 0.16.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Alpha Tau Medical's Debt-to-Equity or its related term are showing as below:

DRTS' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.05 Med: 0.1 Max: 0.16
Current: 0.16

During the past 5 years, the highest Debt-to-Equity Ratio of Alpha Tau Medical was 0.16. The lowest was 0.05. And the median was 0.10.

DRTS's Debt-to-Equity is ranked worse than
51.69% of 1068 companies
in the Biotechnology industry
Industry Median: 0.14 vs DRTS: 0.16

Alpha Tau Medical Debt-to-Equity Historical Data

The historical data trend for Alpha Tau Medical's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alpha Tau Medical Debt-to-Equity Chart

Alpha Tau Medical Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

0.05

0.16

Alpha Tau Medical Quarterly Data
	Dec19	Jun20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Debt-to-Equity	Get a 7-Day Free Trial										0.05	0.07	0.07	0.07	0.16

Competitive Comparison of Alpha Tau Medical's Debt-to-Equity

For the Biotechnology subindustry, Alpha Tau Medical's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Alpha Tau Medical's Debt-to-Equity Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Alpha Tau Medical's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Alpha Tau Medical's Debt-to-Equity falls into.

Alpha Tau Medical Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Alpha Tau Medical's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1.062	+	12.214)	/	84.475
	=	0.16

Alpha Tau Medical's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1.062	+	12.214)	/	84.475
	=	0.16

Alpha Tau Medical (NAS:DRTS) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Alpha Tau Medical Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Alpha Tau Medical's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Alpha Tau Medical (Alpha Tau Medical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alpha Tau Medical Ltd (NAS:DRTS) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

5 Kiryat Hamada Street, Building B3, 4th Floor, Jerusalem, ISR, 9777605

Website

https://www.alphatau.com

Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors.